SCHEMBL21982017

SCHEMBL21982017

CSc1cc(F)cc(Nc2cc(NCC3CC3)nc(-c3cccc(C(C)(F)F)n3)n2)c1

nearest known ligand 0.58

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ IDH1 O75874 20/20 0.58
▸ IDH2 P48735 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16391620 0.92 IDH1 (0.66) IDH1IDH2
SCHEMBL21976980 0.90 IDH1 (0.61) IDH1IDH2
SCHEMBL21980585 0.89 IDH1 (0.62) IDH1IDH2
SCHEMBL20018045 0.88 IDH1 (0.66) IDH1IDH2
SCHEMBL16392200 0.85 IDH1 (0.57) IDH1IDH2
SCHEMBL21982016 0.85 IDH1 (0.48) IDH1IDH2
SCHEMBL16391756 0.84 IDH1 (0.79) IDH1IDH2
SCHEMBL21977579 0.83 IDH1 (0.73) IDH1IDH2
SCHEMBL20018036 0.81 IDH1 (0.75) IDH1IDH2
SCHEMBL16392189 0.81 IDH1 (0.64) IDH1IDH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3019480-B1 2,4- OR 4,6-DIAMINOPYRIMIDINE COMPOUNDS AS IDH2 MUTANTS INHIBITORS FOR THE TREATMENT OF CANCER AGIOS PHARMACEUTICALS INC (US) 2020-05-06 — — EP disclosed
Send feedback